TrialArteriosclerosis, thrombosis, and vascular biology2015

Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model.

Mark R Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.